Unichem Laboratories, a leading pharmaceutical company today announced that it has received approval for its bulk drug [active pharmaceutical ingredients (API)] facility situated at Pithampur from US Food and Drug Administration (USFDA).

With this approval, both bulk drug facilities situated at Roha, Maharashtra and Pithampur, Madhya Pradesh are duly approved by US FDA.

The company`s formulation facilities at Goa and Ghaziabad are already approved by USFDA.

The company is engaged in manufacturing formulations and active pharmaceutical ingredients (APIs).

Shares of the company gained Rs 3.25, or 1.3%, to settle at Rs 252.60. The total volume of shares traded was 6,771 at the BSE (Monday).